Dr. Ted Skolarus (MT-DIRC fellow, 2014 cohort) recently received word from the National Cancer Institute of funding for his R01 entitled De-implementation of low value castration for men with prostate cancer.
According to Dr. Skolarus, the study will “transform how and why low value castration is practiced, and advance the science behind stopping low value, even harmful, cancer treatments.”